Financial Snapshot

Revenue
$10.26M
TTM
Gross Margin
98.63%
TTM
Net Earnings
-$45.51M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
122.25%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$8.735M
Q3 2024
Cash
Q3 2024
P/E
-0.7517
Nov 29, 2024 EST
Free Cash Flow
-$10.18M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989
Revenue $10.02M $10.16M $10.65M $10.84M $10.00M $10.43M $9.898M $7.527M $7.878M $9.843M $15.00M $16.97M $14.76M $16.00M $8.590M $8.370M $16.39M $14.94M $6.000M $3.700M $10.38M $18.39M $1.090M $1.020M $3.210M $10.43M $13.09M $21.16M $2.000M $5.810M $2.650M $5.000M $5.400M $4.860M $4.860M
YoY Change -1.37% -4.57% -1.72% 8.31% -4.07% 5.35% 31.5% -4.46% -19.96% -34.39% -11.61% 14.97% -7.73% 86.26% 2.63% -48.93% 9.71% 149.0% 62.16% -64.35% -43.56% 1587.16% 6.86% -68.22% -69.22% -20.32% -38.14% 958.0% -65.58% 119.25% -47.0% -7.41% 11.11% 0.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989
Revenue $10.02M $10.16M $10.65M $10.84M $10.00M $10.43M $9.898M $7.527M $7.878M $9.843M $15.00M $16.97M $14.76M $16.00M $8.590M $8.370M $16.39M $14.94M $6.000M $3.700M $10.38M $18.39M $1.090M $1.020M $3.210M $10.43M $13.09M $21.16M $2.000M $5.810M $2.650M $5.000M $5.400M $4.860M $4.860M
Cost Of Revenue $212.0K $257.0K $533.0K $530.0K $500.0K $560.0K $500.0K $18.39M $24.75M $340.0K $200.0K $9.680M $0.00 $0.00 $0.00 $270.0K $3.820M $720.0K $1.390M $450.0K $10.00K $10.00K $110.0K $110.0K
Gross Profit $9.811M $9.905M $10.12M $10.30M $9.500M $9.870M $9.400M -$10.86M -$16.88M $9.500M $14.80M $7.300M $1.020M $3.210M $10.43M $12.81M $17.33M $1.280M $4.420M $2.200M $4.990M $5.390M $4.750M $4.750M
Gross Profit Margin 97.88% 97.47% 94.99% 95.06% 94.96% 94.65% 94.97% -144.28% -214.27% 96.52% 98.65% 43.01% 100.0% 100.0% 100.0% 97.86% 81.9% 64.0% 76.08% 83.02% 99.8% 99.81% 97.74% 97.74%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989
Selling, General & Admin $18.65M $19.65M $17.30M $12.13M $11.56M $14.79M $14.07M $14.83M $11.88M $11.04M $11.29M $10.42M $8.270M $10.26M $8.700M $8.260M $9.980M $10.37M $8.090M $7.760M $6.880M $12.32M $20.85M $25.96M $5.590M $7.270M $6.080M $4.390M $1.260M $4.790M $3.120M $3.290M $2.110M $1.460M $1.460M
YoY Change -5.09% 13.59% 42.6% 4.93% -21.84% 5.12% -5.12% 24.83% 7.61% -2.21% 8.35% 26.0% -19.4% 17.93% 5.33% -17.23% -3.76% 28.18% 4.25% 12.79% -44.16% -40.91% -19.68% 364.4% -23.11% 19.57% 38.5% 248.41% -73.7% 53.53% -5.17% 55.92% 44.52% 0.0%
% of Gross Profit 190.06% 198.36% 170.99% 117.77% 121.68% 149.85% 149.68% 116.21% 76.28% 142.74% 2545.1% 174.14% 69.7% 47.46% 25.33% 98.44% 108.37% 141.82% 65.93% 39.15% 30.74% 30.74%
Research & Development $39.50M $43.28M $34.88M $23.07M $22.30M $24.41M $45.10M $18.00M $26.70M $13.66M $12.93M $15.49M $13.69M $11.37M $9.930M $13.23M $14.78M $14.59M $13.71M $12.66M $14.39M $12.06M $29.07M $17.42M $10.44M $24.86M $25.12M $15.65M $3.190M $17.68M $12.90M $7.490M $5.810M $5.530M $5.530M
YoY Change -8.74% 24.06% 51.22% 3.43% -8.65% -45.86% 150.53% -32.58% 95.46% 5.67% -16.56% 13.14% 20.43% 14.5% -24.94% -10.49% 1.3% 6.42% 8.29% -12.02% 19.32% -58.51% 66.88% 66.86% -58.0% -1.04% 60.51% 390.6% -81.96% 37.05% 72.23% 28.92% 5.06% 0.0%
% of Gross Profit 402.57% 436.92% 344.84% 223.96% 234.76% 247.35% 479.74% 143.78% 87.34% 212.22% 1707.84% 325.23% 238.35% 196.1% 90.31% 249.22% 400.0% 586.36% 150.1% 107.79% 116.42% 116.42%
Depreciation & Amortization $255.0K $233.0K $158.0K $140.0K $130.0K $180.0K $240.0K $190.0K $160.0K $160.0K $140.0K $130.0K $110.0K $690.0K $750.0K $1.000M $1.300M $1.440M $1.020M $1.080M $1.510M $2.440M $26.63M $11.15M $990.0K $2.490M $2.100M $2.420M $760.0K $2.350M $1.520M $710.0K $550.0K $530.0K $530.0K
YoY Change 9.44% 47.47% 12.86% 7.69% -27.78% -25.0% 26.32% 18.75% 0.0% 14.29% 7.69% 18.18% -84.06% -8.0% -25.0% -23.08% -9.72% 41.18% -5.56% -28.48% -38.11% -90.84% 138.83% 1026.26% -60.24% 18.57% -13.22% 218.42% -67.66% 54.61% 114.08% 29.09% 3.77% 0.0%
% of Gross Profit 2.6% 2.35% 1.56% 1.36% 1.37% 1.82% 2.55% 1.68% 0.95% 1.78% 1093.14% 30.84% 23.87% 16.39% 13.96% 59.38% 53.17% 69.09% 14.23% 10.2% 11.16% 11.16%
Operating Expenses $39.50M $43.28M $34.88M $23.07M $22.30M $24.41M $45.10M $18.00M $26.70M $13.66M $12.93M $15.49M $13.69M $21.64M $18.63M $21.49M $24.76M $24.99M $21.87M $20.49M $21.35M $24.85M $73.26M $57.83M $16.83M $32.33M $31.60M $20.56M $4.450M $22.48M $16.01M $10.78M $7.910M $6.990M $6.990M
YoY Change -8.74% 24.06% 51.22% 3.43% -8.65% -45.86% 150.53% -32.58% 95.46% 5.67% -16.56% 13.14% -36.73% 16.16% -13.31% -13.21% -0.92% 14.27% 6.73% -4.03% -14.08% -66.08% 26.68% 243.61% -47.94% 2.31% 53.7% 362.02% -80.2% 40.41% 48.52% 36.28% 13.16% 0.0%
Operating Profit -$48.33M -$53.02M -$42.07M -$24.90M -$24.36M -$29.33M -$49.76M -$58.04M -$56.48M -$15.86M -$9.416M -$18.62M -$7.203M -$56.81M -$13.62M -$21.90M -$18.79M -$3.230M -$3.170M -$18.06M -$13.81M -$5.790M -$2.520M -$2.240M -$2.240M
YoY Change -8.84% 26.04% 68.95% 2.23% -16.97% -41.05% -14.26% 2.76% 256.08% 68.45% -49.43% 158.52% 317.11% -37.81% 16.55% 481.73% 1.89% -82.45% 30.77% 138.51% 129.76% 12.5% 0.0%

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989
Interest Expense $2.938M $1.119M $0.00 $0.00 $791.0K $3.926M $3.966M $2.777M $3.325M $3.749M $3.842M $204.2K -$2.660M $710.0K $220.0K $990.0K $1.520M $1.380M $890.0K $130.0K -$270.0K -$4.190M -$11.38M $1.420M $1.760M $1.860M -$220.0K -$220.0K -$60.00K -$200.0K -$210.0K -$200.0K -$210.0K -$190.0K -$190.0K
YoY Change 162.56% -100.0% -79.85% -1.01% 42.82% -16.48% -11.31% -2.41% 1781.62% -107.68% -474.65% 222.73% -77.78% -34.87% 10.14% 55.06% 584.62% -148.15% -93.56% -63.18% -901.41% -19.32% -5.38% -945.45% 0.0% 266.67% -70.0% -4.76% 5.0% -4.76% 10.53% 0.0%
% of Operating Profit
Other Income/Expense, Net $919.0K -$3.652M -$3.371M -$5.010M -$7.785M -$3.242M -$3.557M -$2.372M -$2.500M -$2.866M -$2.906M $2.203M -$2.656M $490.0K $0.00 $10.00K -$110.0K -$160.0K $130.0K $1.590M -$1.450M $1.260M $1.690M $10.00K $0.00 $10.00K $2.350M $1.200M
YoY Change -125.16% 8.34% -32.71% -35.65% 140.13% -8.86% 49.96% -5.12% -12.79% -1.35% -231.9% -182.93% -642.12% -100.0% -109.09% -31.25% -223.08% -91.82% -209.66% -215.08% -25.44% 16800.0% -100.0% -99.57% 95.83%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989
Pretax Income -$47.41M -$56.67M -$45.44M -$29.91M -$32.14M -$32.58M -$53.32M -$60.41M -$58.98M -$18.73M -$12.32M -$16.42M -$9.860M -$4.440M -$9.820M -$12.12M -$6.960M -$8.830M -$14.85M -$15.07M -$12.68M -$82.32M -$81.86M -$350.4M -$12.11M -$21.40M -$16.65M -$2.240M -$3.220M -$18.26M -$14.02M -$5.990M -$2.730M -$2.430M -$2.430M
YoY Change -16.34% 24.73% 51.91% -6.94% -1.35% -38.9% -11.74% 2.42% 214.9% 52.03% -24.97% 66.53% 122.07% -54.79% -18.98% 74.14% -21.18% -40.54% -1.46% 18.85% -84.6% 0.56% -76.63% 2793.06% -43.41% 28.53% 643.3% -30.43% -82.37% 30.24% 134.06% 119.41% 12.35% 0.0%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$47.40M -$56.70M -$45.40M -$29.91M -$32.14M -$32.58M -$53.32M -$60.41M -$58.98M -$18.73M -$12.32M -$16.42M -$9.859M -$4.440M -$9.820M -$12.12M -$6.960M -$8.830M -$14.85M -$15.07M -$12.68M -$82.32M -$81.86M -$350.4M -$12.11M -$21.40M -$16.65M -$2.240M -$3.220M -$18.26M -$14.02M -$5.990M -$2.730M -$2.430M -$2.430M
YoY Change -16.4% 24.89% 51.8% -6.95% -1.33% -38.9% -11.74% 2.42% 214.92% 52.0% -24.94% 66.52% 122.05% -54.79% -18.98% 74.14% -21.18% -40.54% -1.46% 18.85% -84.6% 0.56% -76.63% 2793.06% -43.41% 28.53% 643.3% -30.43% -82.37% 30.24% 134.06% 119.41% 12.35% 0.0%
Net Earnings / Revenue -472.91% -557.96% -426.33% -276.03% -321.28% -312.38% -538.66% -802.59% -748.68% -190.28% -82.14% -96.73% -66.78% -27.75% -114.32% -144.8% -42.46% -59.1% -247.5% -407.3% -122.16% -447.63% -7510.09% -34348.04% -377.26% -205.18% -127.2% -10.59% -161.0% -314.29% -529.06% -119.8% -50.56% -50.0% -50.0%
Basic Earnings Per Share -$8.96 $0.61 -$0.50 -$0.61 -$0.97
Diluted Earnings Per Share -$8.96 $0.61 -$0.50 -$0.61 -$0.97 -$983.7K -$1.787M -$2.274M -$2.391M -$1.090M -$748.0K -$1.039M -$645.7K -$296.2K -$754.8K -$955.8K -$633.9K -$900.1K -$1.545M -$1.765M -$1.761M -$12.76M -$12.85M -$98.97M -$5.659M -$10.59M -$8.409M -$1.244M -$573.0K -$4.755M -$4.721M -$2.773M -$2.022M -$1.827M -$1.827M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989
Cash & Short-Term Investments $56.33M $85.62M $115.9M $168.5M $20.50M $24.30M $60.20M $44.50M $82.20M $49.80M $58.20M $55.50M $37.70M $40.40M $25.00M $28.90M $41.50M $36.70M $44.20M $49.50M $35.10M $36.60M $51.20M $75.10M $21.40M $57.90M $30.60M $50.10M $20.00M $5.400M $25.30M $6.700M $500.0K $500.0K
YoY Change -34.21% -26.11% -31.23% 721.95% -15.64% -59.63% 35.28% -45.86% 65.06% -14.43% 4.86% 47.21% -6.68% 61.6% -13.49% -30.36% 13.08% -16.97% -10.71% 41.03% -4.1% -28.52% -31.82% 250.93% -63.04% 89.22% -38.92% 150.5% 270.37% -78.66% 277.61% 1240.0% 0.0%
Cash & Equivalents $26.68M $19.66M $40.01M $129.6M $15.40M $23.60M $38.30M $26.00M $33.10M $7.700M $9.600M $12.70M $15.10M $7.800M $7.300M $10.20M $17.40M $18.80M $22.30M $22.70M $27.70M $26.90M $38.90M $52.40M $2.800M $17.70M $2.200M $38.20M $11.90M $2.700M $17.00M $700.0K $500.0K $500.0K
Short-Term Investments $29.65M $65.97M $75.87M $38.90M $5.100M $600.0K $21.90M $18.40M $49.10M $42.00M $48.60M $42.80M $22.60M $32.60M $17.80M $18.70M $24.10M $17.80M $21.90M $26.80M $7.400M $9.700M $12.30M $22.70M $18.60M $40.20M $28.40M $11.80M $8.100M $2.800M $8.200M $6.000M $0.00 $0.00
Other Short-Term Assets $1.780M $3.521M $3.267M $1.200M $1.300M $800.0K $1.000M $1.300M $1.200M $500.0K $500.0K $400.0K $700.0K $600.0K $800.0K $400.0K $300.0K $500.0K $700.0K $800.0K $1.000M $5.300M $1.700M $1.600M $100.0K $300.0K $300.0K $200.0K $100.0K $200.0K $300.0K $200.0K $100.0K $100.0K
YoY Change -49.45% 7.77% 172.25% -7.69% 62.5% -20.0% -23.08% 8.33% 140.0% 0.0% 25.0% -42.86% 16.67% -25.0% 100.0% 33.33% -40.0% -28.57% -12.5% -20.0% -81.13% 211.76% 6.25% 1500.0% -66.67% 0.0% 50.0% 100.0% -50.0% -33.33% 50.0% 100.0% 0.0%
Inventory $0.00 $1.200M $1.300M $600.0K $700.0K $500.0K $200.0K $200.0K $200.0K
Prepaid Expenses
Receivables $2.794M $2.975M $3.224M $3.000M $3.200M $2.900M $3.100M $2.500M $2.100M $2.000M $1.500M $900.0K $0.00 $100.0K $500.0K $100.0K $200.0K $1.300M $1.000M $1.200M $2.400M $1.700M $1.300M $400.0K $100.0K $700.0K $4.600M $1.500M $2.800M $1.500M $700.0K $200.0K $200.0K $200.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $500.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $60.91M $92.12M $122.4M $172.8M $25.00M $28.00M $64.30M $48.20M $85.50M $52.20M $60.20M $56.90M $38.50M $41.10M $26.40M $29.30M $42.00M $38.50M $45.90M $51.50M $38.50M $43.70M $54.70M $77.10M $21.60M $58.90M $36.70M $53.10M $23.50M $7.800M $26.80M $7.300M $1.000M $1.000M
YoY Change -33.88% -24.72% -29.18% 591.2% -10.71% -56.45% 33.4% -43.63% 63.79% -13.29% 5.8% 47.79% -6.33% 55.68% -9.9% -30.24% 9.09% -16.12% -10.87% 33.77% -11.9% -20.11% -29.05% 256.94% -63.33% 60.49% -30.89% 125.96% 201.28% -70.9% 267.12% 630.0% 0.0%
Property, Plant & Equipment $3.490M $5.090M $6.254M $7.200M $300.0K $300.0K $400.0K $400.0K $300.0K $400.0K $400.0K $400.0K $500.0K $300.0K $700.0K $1.400M $2.600M $4.400M $5.300M $3.400M $2.500M $3.800M $11.10M $7.900M $2.100M $1.900M $17.20M $16.20M $14.70M $17.20M $16.50M $2.800M $2.100M $2.100M
YoY Change -31.43% -18.61% -13.14% 2300.0% 0.0% -25.0% 0.0% 33.33% -25.0% 0.0% 0.0% -20.0% 66.67% -57.14% -50.0% -46.15% -40.91% -16.98% 55.88% 36.0% -34.21% -65.77% 40.51% 276.19% 10.53% -88.95% 6.17% 10.2% -14.53% 4.24% 489.29% 33.33% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $23.96M $14.60M $0.00 $800.0K $10.70M $3.200M $0.00 $2.600M $2.400M
YoY Change -100.0% 64.14% -100.0% -92.52% 234.38% -100.0% 8.33%
Other Assets $3.902M $2.657M $726.0K $800.0K $800.0K $200.0K $200.0K $200.0K $200.0K $200.0K $300.0K $300.0K $200.0K $300.0K $0.00 $200.0K $200.0K $400.0K $700.0K $700.0K $1.200M $1.100M $5.000M $400.0K $100.0K $4.800M $4.400M $3.800M $2.700M $1.900M $1.500M $1.600M $900.0K $900.0K
YoY Change 46.86% 265.98% -9.25% 0.0% 300.0% 0.0% 0.0% 0.0% 0.0% -33.33% 0.0% 50.0% -33.33% -100.0% 0.0% -50.0% -42.86% 0.0% -41.67% 9.09% -78.0% 1150.0% 300.0% -97.92% 9.09% 15.79% 40.74% 42.11% 26.67% -6.25% 77.78% 0.0%
Total Long-Term Assets $16.37M $16.73M $39.93M $31.60M $10.10M $9.400M $9.500M $9.600M $9.500M $10.40M $20.40M $12.90M $9.700M $9.500M $9.700M $10.70M $11.80M $13.80M $15.00M $15.80M $17.20M $18.70M $90.10M $105.6M $7.300M $7.300M $22.30M $20.70M $17.80M $19.70M $18.50M $4.900M $3.500M $3.500M
YoY Change -2.12% -58.1% 26.35% 212.87% 7.45% -1.05% -1.04% 1.05% -8.65% -49.02% 58.14% 32.99% 2.11% -2.06% -9.35% -9.32% -14.49% -8.0% -5.06% -8.14% -8.02% -79.25% -14.68% 1346.58% 0.0% -67.26% 7.73% 16.29% -9.64% 6.49% 277.55% 40.0% 0.0%
Total Assets $77.28M $108.8M $162.3M $204.4M $35.10M $37.40M $73.80M $57.80M $95.00M $62.60M $80.60M $69.80M $48.20M $50.60M $36.10M $40.00M $53.80M $52.30M $60.90M $67.30M $55.70M $62.40M $144.8M $182.7M $28.90M $66.20M $59.00M $73.80M $41.30M $27.50M $45.30M $12.20M $4.500M $4.500M
YoY Change
Accounts Payable $3.172M $3.193M $6.417M $4.200M $4.500M $2.900M $5.400M $5.900M $4.200M $2.300M $2.000M $2.500M $2.400M $2.600M $1.600M $2.000M $3.200M $1.500M $1.400M $1.600M $500.0K $700.0K $2.000M $2.200M $600.0K $1.600M $2.300M $2.800M $700.0K $1.400M $1.600M $1.500M $1.200M $1.200M
YoY Change -0.66% -50.24% 52.79% -6.67% 55.17% -46.3% -8.47% 40.48% 82.61% 15.0% -20.0% 4.17% -7.69% 62.5% -20.0% -37.5% 113.33% 7.14% -12.5% 220.0% -28.57% -65.0% -9.09% 266.67% -62.5% -30.43% -17.86% 300.0% -50.0% -12.5% 6.67% 25.0% 0.0%
Accrued Expenses $10.35M $6.820M $7.021M $5.400M $2.100M $3.500M $2.800M $2.700M $1.900M $2.000M $1.900M $1.500M $1.400M $900.0K $1.000M $600.0K $1.200M $1.500M $2.900M $1.100M $2.400M $3.300M $5.900M $5.600M $2.800M $3.800M $1.900M $2.000M $1.000M $1.200M $900.0K $600.0K $300.0K $300.0K
YoY Change 51.69% -2.86% 30.02% 157.14% -40.0% 25.0% 3.7% 42.11% -5.0% 5.26% 26.67% 7.14% 55.56% -10.0% 66.67% -50.0% -20.0% -48.28% 163.64% -54.17% -27.27% -44.07% 5.36% 100.0% -26.32% 100.0% -5.0% 100.0% -16.67% 33.33% 50.0% 100.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.600M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $500.0K $500.0K
YoY Change -100.0% -100.0% 0.0%
Long-Term Debt Due $0.00 $600.0K $0.00 $6.900M $5.900M $4.900M $4.600M $5.700M $2.600M $0.00 $400.0K $1.200M $1.300M $1.100M $300.0K $2.100M $3.100M $2.000M $300.0K $200.0K $100.0K $100.0K $0.00 $200.0K $300.0K $200.0K $200.0K $200.0K
YoY Change -100.0% -100.0% 16.95% 20.41% 6.52% -19.3% 119.23% -100.0% -66.67% -7.69% 18.18% 266.67% -85.71% -32.26% 55.0% 566.67% 50.0% 100.0% 0.0% -100.0% -33.33% 50.0% 0.0% 0.0%
Total Short-Term Liabilities $13.52M $10.01M $13.44M $10.10M $6.500M $13.30M $14.10M $13.50M $10.80M $10.10M $6.600M $4.000M $3.800M $3.500M $3.000M $2.600M $6.600M $6.000M $9.900M $4.700M $4.400M $7.400M $11.90M $9.700M $4.500M $9.300M $4.300M $4.900M $1.800M $2.900M $2.800M $2.300M $2.400M $2.400M
YoY Change 34.99% -25.49% 33.05% 55.38% -51.13% -5.67% 4.44% 25.0% 6.93% 53.03% 65.0% 5.26% 8.57% 16.67% 15.38% -60.61% 10.0% -39.39% 110.64% 6.82% -40.54% -37.82% 22.68% 115.56% -51.61% 116.28% -12.24% 172.22% -37.93% 3.57% 21.74% -4.17% 0.0%
Long-Term Debt $0.00 $0.00 $0.00 $300.0K $0.00 $28.60M $35.70M $14.90M $19.60M $22.60M $27.90M $29.80M $0.00 $0.00 $0.00 $0.00 $0.00 $700.0K $2.000M $5.700M $5.300M $10.30M $7.500M $4.200M $1.000M $700.0K $2.000M $1.700M $1.700M $1.800M $1.800M $200.0K $800.0K $800.0K
YoY Change -100.0% -100.0% -19.89% 139.6% -23.98% -13.27% -19.0% -6.38% -100.0% -65.0% -64.91% 7.55% -48.54% 37.33% 78.57% 320.0% 42.86% -65.0% 17.65% 0.0% -5.56% 0.0% 800.0% -75.0% 0.0%
Other Long-Term Liabilities $44.10M $52.28M $58.16M $63.30M $62.50M $0.00 $0.00 $0.00 $100.0K $200.0K $900.0K $1.700M $4.500M $1.700M $0.00 $200.0K $300.0K $9.600M $11.10M $8.600M $7.100M $12.00M $12.10M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -15.66% -10.1% -8.13% 1.28% -100.0% -50.0% -77.78% -47.06% -62.22% 164.71% -100.0% -33.33% -96.88% -13.51% 29.07% 21.13% -40.83% -0.83%
Total Long-Term Liabilities $44.10M $52.28M $58.16M $63.60M $62.50M $28.60M $35.70M $14.90M $19.70M $22.80M $28.80M $31.50M $4.500M $1.700M $0.00 $200.0K $300.0K $10.30M $13.10M $14.30M $12.40M $22.30M $19.60M $4.200M $1.000M $700.0K $2.000M $1.700M $1.700M $1.800M $1.800M $200.0K $800.0K $800.0K
YoY Change -15.66% -10.1% -8.56% 1.76% 118.53% -19.89% 139.6% -24.37% -13.6% -20.83% -8.57% 600.0% 164.71% -100.0% -33.33% -97.09% -21.37% -8.39% 15.32% -44.39% 13.78% 366.67% 320.0% 42.86% -65.0% 17.65% 0.0% -5.56% 0.0% 800.0% -75.0% 0.0%
Total Liabilities $57.61M $62.30M $71.59M $73.70M $69.00M $41.90M $49.80M $28.50M $30.50M $32.80M $35.40M $35.50M $8.300M $5.100M $3.000M $2.800M $7.000M $16.40M $22.90M $19.00M $16.90M $29.60M $31.40M $13.90M $5.500M $10.00M $6.300M $6.600M $3.500M $4.700M $4.700M $2.600M $3.200M $3.200M
YoY Change -7.52% -12.99% -2.86% 6.81% 64.68% -15.86% 74.74% -6.56% -7.01% -7.34% -0.28% 327.71% 62.75% 70.0% 7.14% -60.0% -57.32% -28.38% 20.53% 12.43% -42.91% -5.73% 125.9% 152.73% -45.0% 58.73% -4.55% 88.57% -25.53% 0.0% 80.77% -18.75% 0.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989
Basic Shares Outstanding 5.293M shares 93.39M shares 91.57M shares 48.67M shares 33.18M shares
Diluted Shares Outstanding 5.293M shares 93.39M shares 91.57M shares 48.67M shares 33.18M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $34.207 Million

About CURIS INC

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. The company is headquartered in Lexington, Massachusetts and currently employs 48 full-time employees. The company went IPO on 2000-08-01. The firm is focused on the development of emavusertib (CA-4948), an orally available, small molecule inhibitor of Interleukin-1 receptor associated kinase (IRAK4). Emavusertib is undergoing testing in the Phase I/II TakeAim Lymphoma study in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the Phase I/II TakeAim Leukemia study in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS). Its other clinical programs include Fimepinostat and CA-170. Fimepinostat is an oral, dual inhibitor of histone deacetylase (HDAC), and phosphotidyl-inositol 3 kinase (PI3K) enzymes. CA-170 is an oral small molecule drug candidate that is designed to selectively target V-domain Ig Suppressor of T-cell Activation (VISTA) and PDL1 immune checkpoint proteins.

Industry: Biological Products, (No Diagnostic Substances) Peers: X4 Pharmaceuticals, Inc Zeo ScientifiX, Inc. Bolt Biotherapeutics, Inc. Senti Biosciences, Inc. Equillium, Inc. Korro Bio, Inc. SYNLOGIC, INC. Pyxis Oncology, Inc. SQZ Biotechnologies Co